Total Payments
$2,187
2024 Payments
$38.75
Companies
14
Transactions
28
Medicare Patients
309
Medicare Billing
$41,389
Payment Breakdown by Category
Food & Beverage$2,187 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,187 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $350.24 | 5 | $0 (2019) |
| Amarin Pharma Inc. | $302.28 | 3 | $0 (2019) |
| Novo Nordisk Inc | $300.47 | 4 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $296.82 | 3 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $272.66 | 3 | $0 (2018) |
| IDORSIA PHARMACEUTICALS US INC | $105.43 | 1 | $0 (2022) |
| PFIZER INC. | $99.90 | 1 | $0 (2017) |
| AbbVie, Inc. | $99.89 | 1 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $91.53 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $86.13 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38.75 | 2 | Indivior Inc. ($38.75) |
| 2022 | $105.43 | 1 | IDORSIA PHARMACEUTICALS US INC ($105.43) |
| 2020 | $89.79 | 1 | Teva Pharmaceuticals USA, Inc. ($89.79) |
| 2019 | $410.96 | 7 | Janssen Pharmaceuticals, Inc ($198.86) |
| 2018 | $927.56 | 10 | Novo Nordisk Inc ($284.19) |
| 2017 | $614.88 | 7 | AstraZeneca Pharmaceuticals LP ($196.62) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/15/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: OUD | ||||||
| 06/04/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: OUD | ||||||
| 11/07/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $105.43 | General |
| Category: INSOMNIA | ||||||
| 01/18/2020 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $89.79 | General |
| Category: Central Nervous System | ||||||
| 07/11/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $86.13 | General |
| Category: Cardiovascular | ||||||
| 06/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/30/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.28 | General |
| 04/18/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $90.63 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/20/2019 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $11.41 | General |
| Category: Addiction Medicine | ||||||
| 03/14/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $98.28 | General |
| Category: Hypertriglyceridemia | ||||||
| 02/12/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $104.04 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/12/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $110.69 | General |
| Category: Diabetes | ||||||
| 12/06/2018 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $99.89 | General |
| Category: Virology | ||||||
| 10/23/2018 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $111.94 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/03/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $70.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/02/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $94.58 | General |
| Category: Central Nervous System | ||||||
| 06/28/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $73.64 | General |
| Category: Diabetes | ||||||
| 06/26/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $99.86 | General |
| Category: Diabetes | ||||||
| 06/12/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $76.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/24/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $112.45 | General |
| Category: Central Nervous System | ||||||
| 03/01/2018 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $78.11 | General |
| Category: Anemia | ||||||
| 12/14/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $92.06 | General |
| Category: Hypertriglyceridemia | ||||||
| 08/17/2017 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $94.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/24/2017 | Valeant Pharmaceuticals North America LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $53.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/22/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $102.38 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 121 | 231 | $40,721 | $9,718 |
| 2022 | 2 | 52 | 131 | $35,840 | $10,362 |
| 2021 | 2 | 80 | 158 | $33,565 | $12,292 |
| 2020 | 2 | 56 | 144 | $26,900 | $9,017 |
Total Patients
309
Total Services
664
Medicare Billing
$41,389
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 65 | $20,475 | $5,246 | 25.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 34 | $7,675 | $1,853 | 24.1% |
| 99484 | Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | Office | 2023 | 29 | 59 | $8,260 | $1,717 | 20.8% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 35 | 73 | $4,311 | $901.55 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 88 | $27,265 | $8,062 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 43 | $8,575 | $2,300 | 26.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 44 | 98 | $24,565 | $8,791 | 35.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 60 | $9,000 | $3,501 | 38.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 31 | 91 | $13,650 | $5,030 | 36.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 25 | 53 | $13,250 | $3,987 | 30.1% |
About Dr. Steven Selip, MD
Dr. Steven Selip, MD is a Family Medicine healthcare provider based in Latrobe, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972581734.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Selip, MD has received a total of $2,187 in payments from pharmaceutical and medical device companies, with $38.75 received in 2024. These payments were reported across 28 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,187).
As a Medicare-enrolled provider, Selip has provided services to 309 Medicare beneficiaries, totaling 664 services with total Medicare billing of $41,389. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Latrobe, PA
- Active Since 01/03/2006
- Last Updated 12/28/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1972581734
Products in Payments
- Vascepa (Drug) $302.28
- AUSTEDO (Drug) $296.82
- XARELTO (Drug) $259.61
- ELIQUIS (Drug) $186.03
- Ozempic (Drug) $184.33
- QUVIVIQ (Drug) $105.43
- SYMBICORT (Drug) $102.38
- Mavyret (Drug) $99.89
- Tresiba (Drug) $99.86
- BYDUREON (Drug) $94.24
- BELSOMRA (Drug) $91.53
- INVOKANA (Drug) $90.63
- INJECTAFER (Drug) $78.11
- FARXIGA (Drug) $76.04
- RELISTOR (Drug) $53.75
- SUBLOCADE (Drug) $38.75
- Zubsolv (Drug) $11.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Latrobe
Matthew Woleslagle, D.o, D.O
Family Medicine — Payments: $1,682
Family Medicine $1,682
Dr. Lindsey Beabout, D.o, D.O
Family Medicine — Payments: $1,542
Family Medicine $1,542
David Yuna
Family Medicine — Payments: $1,047
Family Medicine $1,047
David Ream, Md, MD
Family Medicine — Payments: $761.53
Family Medicine $761.53
Dr. Justin Mccray, M.d, M.D
Family Medicine — Payments: $368.00
Family Medicine $368.00
Donald Jakubek, Md, MD
Family Medicine — Payments: $350.24
Family Medicine $350.24